Trade Show News
Stay updated with the latest trade show news through detailed press releases. Learn about upcoming events, key highlights, and industry trends. Get insights into significant trade show announcements, exhibitor information, and post-event analyses.
Jun 5, 2026 at 7:30 PM
OrsoBio to Present Preclinical and Clinical Data from its Mitochondrial Protonophore Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
MENLO PARK, Calif.--(BUSINESS WIRE)--At ADA 2026, OrsoBio to share clinical and preclinical data highlighting potential multi-system benefits of mitochondrial protonophore mechanism....
Jun 5, 2026 at 7:30 PM
Verdiva Bio Presents Preclinical Data on Investigational Obesity Drug Candidates at the American Diabetes Association 86th Scientific Sessions
LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Verdiva Bio Limited (“Verdiva Bio” or “the Company”), a clinical-stage biotechnology company advancing a scalable, once-weekly oral obesity product pipeline, today announced new preclinical data for VRB-103, a once-weekly oral amylin receptor-selective amylin analog, and VRB-104, a unimolecular amylin and GLP-1 receptor dual agonist. These data are being presented in poster sessions at the 86th Scientific Sessions of the American Diabetes Association (AD...
Jun 5, 2026 at 4:01 PM
Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference. Tempus Founder and CEO Eric Lefkofsky will participate in a fireside chat at 2:00 p.m. ET on Monday, June 8. A live webcast of the conversation will be available here. About Tempus Tempus is a technology company advancing precision medicine through the practi...
Jun 5, 2026 at 12:00 PM
Feinstein Institutes’ John M. Kane honored with 2026 Schizophrenia International Research Society Lifetime Achievement Award
MANHASSET, N.Y.--(BUSINESS WIRE)--John M. Kane, MD, co-director of the Institute of Behavioral Science at Northwell Health’s Feinstein Institutes for Medical Research, was awarded the 2026 Lifetime Achievement Award from the Schizophrenia International Research Society (SIRS). This recognition celebrates his decades-long contributions that have transformed the understanding, treatment and outcomes for individuals living with schizophrenia worldwide. The SIRS Lifetime Achievement Award is one of...
Jun 5, 2026 at 8:30 AM
Cove Kaz Capital Group Executives to Speak at Astana Mining and Metallurgy Congress, Trans-Caspian Forum in Washington, D.C.
ASTANA, Kazakhstan & WASHINGTON--(BUSINESS WIRE)--Cove Kaz Execs will discuss the Northern Katpar and Upper Kairakty tungsten deposits, among the largest undeveloped tungsten resources globally...
Jun 4, 2026 at 4:05 PM
Macy’s, Inc. to Participate in 6th Annual Evercore Consumer and Retail Conference
NEW YORK--(BUSINESS WIRE)--Macy’s, Inc. to Participate in 6th Annual Evercore Consumer and Retail Conference...
Jun 4, 2026 at 3:16 PM
KI Introduces the Kiaura Collection™ Built With Cognetic Technology™ and Defines Human Performance Seating at Design Days
GREEN BAY, Wis.--(BUSINESS WIRE)--For decades, the seating industry has approached discomfort as something to manage. Chairs became more complex, adding levers, controls, and adjustments intended to help people tolerate long hours of sitting. Yet even as ergonomics evolved, one assumption largely remained unchanged: that sitting itself should still be relatively static. Designed and invented by Aaron DeJule, the Kiaura Collection™ built with Cognetic Technology™, challenges that assumption enti...
Jun 4, 2026 at 11:55 AM
DEWA Opens Registration for WETEX 2026
DUBAI, United Arab Emirates--(BUSINESS WIRE)--DEWA opens registration for WETEX 2026...
Jun 4, 2026 at 10:09 AM
Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced long-term results from the ongoing Phase 3 DUPLEX Study open-label extension (OLE) of FILSPARI® (sparsentan) in the treatment of focal segmental glomerulosclerosis (FSGS). Patients who initiated FILSPARI in the double-blind period and remained on therapy in the OLE maintained durable reductions in proteinuria, resulting in further achievement of clinically meaningful low proteinuria thresholds over time. Pati...
Jun 4, 2026 at 9:11 AM
Boxlight Brings Symphony to Every Space With the New Symphonic Series
DULUTH, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL), a leading provider of educational technology and campus communication solutions, today announced the launch of the Boxlight Symphonic Series — a new family of intelligent IP communication endpoints designed to extend the Boxlight Symphony platform into every classroom, hallway, office, cafeteria, gymnasium, and shared space across campus. The Symphonic Series unifies bells, paging, intercom, synchronized clocks, visual messaging...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.